£95.35

EU Competition Law and Pharmaceuticals (New Horizons in Competition Law and Economics series)

Law

Price data last checked 182 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£95 today · previous high £95 · all-time low £93

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 549 days • 549 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 549 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £95 (289 days, 52.6%)

Price range: £93 - £95

Price levels: 2 different prices over 549 days

Description

This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of dominance, and merger control. The author team comprises academic experts and private practitioners who analyse recent case law at both EU (and UK) and Member State levels – in the context of current issues and future trends, including those related to COVID-19 – and examine the impact of competition law on the behaviour of the pharmaceutical industry. The book carefully considers the balance between competition and innovation, as well as between competition and regulation. It concludes that competition and regulation are not alternatives, but complementary, and that novel ways of taking into account risk and real innovation through competition assessments have been developed. Integrating an overview of competition law, IP law and pharmaceutical regulation, this book will be an ideal read for scholars and graduate students, as well as private and public practitioners interested in pharmaceutical and European law.

Product Specifications

Format: hardcover
ASIN: 1802204407
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 15 November 2022
Listed Since: 22 May 2022

Barcode

No barcode data available

EU Competition Law and Pharmaceuticals (New Horizons in Competition Law and Economics series)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

Competition Law and Patents: A Follow-on Innovation Perspective in the Biopharmaceutical Industry (New Horizons in Competition Law and Economics series)

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Pharmaceuticals, Corporate Crime and Public Health

Pharmaceutical Antitrust: An Analysis of US and EU Law

International Cooperation, Convergence and Harmonization of Pharmaceutical Regulations: A Global Perspective

Research Handbook on International Competition Law

Navigating European Pharmaceutical Law: An Expert's Guide

The Pharmaceutical Industry: A Guide to Historical Records (Studies in British Business Archives)

World Pharmaceutical Industry

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Guide to EU and UK Pharmaceutical Regulatory Law

Guide to EU Pharmaceutical Regulatory Law

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Springer - Innovation and Marketing in Pharmaceutical Industry

Global Issues in Pharmaceutical Marketing

Pharmaceutical Economics (The International Library of Critical Writings in Economics series)

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Competition and Marketing Strategies in the Pharmaceutical Industry (RLE Marketing): 22 (Routledge Library Editions: Marketing)

Equitable Access to High-Cost Pharmaceuticals

EU Competition Law and Intellectual Property Rights (Elgar Competition Law and Practice series)